erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hoarseness D006685 2 associated lipids
Occupational Injuries D060051 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Singh N et al. Legionella infection in liver transplant recipients: implications for management. 1993 Transplantation pmid:8279037
Morales JM et al. Severe reversible cyclosporine-induced acute renal failure. A role for urinary PGE2 deficiency? 1988 Transplantation pmid:3293280
Pourmand G et al. Nocardiosis: report of four cases in renal transplant recipients. 1995 Transplant. Proc. pmid:7482893
Benedetti E et al. Treatment of severe pneumonia in kidney transplant recipients. 2001 Nov-Dec Transplant. Proc. pmid:11750552
Claesson K et al. Sirolimus and erythromycin interaction: two cases. 2001 Transplant. Proc. pmid:11377477
Ohmori M et al. Effect of erythromycin on ischemia-reperfusion injury of liver in rats. 2000 Transplant. Proc. pmid:10856595
Lysz K et al. Interaction of erythromycin with cyclosporine. 1988 Transplant. Proc. pmid:3284102
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Koselj M et al. Drug interactions between cyclosporine and rifampicin, erythromycin, and azoles in kidney recipients with opportunistic infections. 1994 Transplant. Proc. pmid:7940889
Moral A et al. Erythromycin ototoxicity in liver transplant patients. 1994 Transpl. Int. pmid:8117405
Mikura S et al. Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke. 2011 Transl Res pmid:21708354
Zhou Y et al. Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats. 2012 Transl Res pmid:22633097
SEIGNEURIN [APROPOS OF THE ADDITION OF ANTIBIOTICS TO BLOOD AND ERYTHROCYTE SEDIMENTS]. 1964 Transfusion (Paris) pmid:14134843
Boreham PF and Upcroft JA The activity of azithromycin against stocks of Giardia intestinalis in vitro and in vivo. 1991 Sep-Oct Trans. R. Soc. Trop. Med. Hyg. pmid:1664150
Swaddiwudhipong W and Kunasol P An outbreak of nosocomial cholera in a 755-bed hospital. 1989 Mar-Apr Trans. R. Soc. Trop. Med. Hyg. pmid:2514477
Crouch AA et al. Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone. 1990 Mar-Apr Trans. R. Soc. Trop. Med. Hyg. pmid:2167523
Robinson BL and Warhurst DC Antimalarial activity of erythromycin. 1972 Trans. R. Soc. Trop. Med. Hyg. pmid:5071047
Roy SK et al. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. 1998 Jul-Aug Trans. R. Soc. Trop. Med. Hyg. pmid:9850410
Brandling-Bennett AD et al. Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum malaria in Kenya. 1988 Trans. R. Soc. Trop. Med. Hyg. pmid:3068845
Rolfe M Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman. 1988 Trans. R. Soc. Trop. Med. Hyg. pmid:3076712
Khan WA et al. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults. 1995 Jan-Feb Trans. R. Soc. Trop. Med. Hyg. pmid:7747291
Nasher MA et al. In vitro studies of antibiotic sensitivities of Streptomyces somaliensis--a cause of human actinomycetoma. 1989 Mar-Apr Trans. R. Soc. Trop. Med. Hyg. pmid:2609384
Burans JP et al. Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistant Vibrio cholerae O1. 1989 Nov-Dec Trans. R. Soc. Trop. Med. Hyg. pmid:2617655
Brown A et al. Nosocomial outbreak of Legionnaire's disease at the Pittsburgh Veterans Administration Medical Center. 1980 Trans. Assoc. Am. Physicians pmid:7245581
Kass EH et al. Genital mycoplasmas as a cause of excess premature delivery. 1981 Trans. Assoc. Am. Physicians pmid:7344224
White A et al. Rapid diagnosis of Legionnaires' disease. 1982 Trans. Am. Clin. Climatol. Assoc. pmid:7048694
Ridgway GL A fresh look at ophthalmia neonatorum. 1986 Trans Ophthalmol Soc U K pmid:3087037
Jackson DM Thermal and chemical burns of the head and neck. 1965 Trans Ophthalmol Soc U K pmid:4289750
Nolan J and Lyle WH Erythromycin in the aqueous. Comparative concentrations form the estolate and from the base. 1976 Trans Ophthalmol Soc U K pmid:797069
Nirankari VS et al. Antibiotic prophylaxis in corneal storage media. 1994 Trans Am Ophthalmol Soc pmid:7886863
KING JT REFRACTORY (STAPHYLOCOCCIC ?) ADENOTONSILLITIS. A BACTERIOLOGIC STUDY. 1964 Trans Am Laryngol Rhinol Otol Soc pmid:14270859
Domingue GJ and Schlegel JU Novel bacterial structures in human blood. II. Bacterial variants as etiologic agents in idiopathic hematuria. 1977 Trans Am Assoc Genitourin Surg pmid:369096
Stamey TA et al. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. 1969 Trans Am Assoc Genitourin Surg pmid:4900657
Allen HF and Mangiaracine AB Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. 1973 Sep-Oct Trans Am Acad Ophthalmol Otolaryngol pmid:4361768
Smith JL et al. Sub-tenon steroid injection for optic neuritis. 1970 Nov-Dec Trans Am Acad Ophthalmol Otolaryngol pmid:5493410
Smith JL Recent observations on the treatment of late ocular syphilis and neurosyphilis. 1969 Nov-Dec Trans Am Acad Ophthalmol Otolaryngol pmid:4190218
Tsujimoto M et al. Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease. 2013 Toxins (Basel) pmid:23965431
Roseghini M et al. Choline esters and biogenic amines in the hypobranchial gland of 55 molluscan species of the neogastropod Muricoidea superfamily. 1996 Toxicon pmid:8835333
Thibault N et al. Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets. 1992 Toxicology pmid:1631904
Kilic B et al. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). 2006 Toxicology pmid:16297520
Rodrigues AD et al. Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochromes P-450. 1988 Toxicology pmid:3394156
Pedersen JM et al. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). 2013 Toxicol. Sci. pmid:24014644
Guo L et al. Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. 2013 Toxicol. Sci. pmid:24052561
Gustafsson F et al. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. 2014 Toxicol. Sci. pmid:24085192
Atienzar F et al. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. 2007 Toxicol. Sci. pmid:17175557
Jin Y et al. From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice. 2016 Toxicol. Sci. pmid:27503388
Guo L et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. 2011 Toxicol. Sci. pmid:21693436
Nioi P et al. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. 2007 Toxicol. Sci. pmid:17567588
Tolosa L et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. 2012 Toxicol. Sci. pmid:22331495
Liu X et al. Potentials and mechanisms of genotoxicity of six pharmaceuticals frequently detected in freshwater environment. 2012 Toxicol. Lett. pmid:22450446
Sorensen EM and Acosta D Erythromycin estolate-induced toxicity in cultured rat hepatocytes. 1985 Toxicol. Lett. pmid:4060187
Saxena RP et al. Coir fibre toxicity: in vivo and in vitro studies. 1982 Toxicol. Lett. pmid:6283694
Mazur CS et al. P-glycoprotein inhibition by the agricultural pesticide propiconazole and its hydroxylated metabolites: Implications for pesticide-drug interactions. 2015 Toxicol. Lett. pmid:25268938
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Mahgoub A et al. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. 2005 Toxicol. Appl. Pharmacol. pmid:15885263
Gracia T et al. Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds. 2007 Toxicol. Appl. Pharmacol. pmid:17822730
Gant TW et al. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. 1995 Toxicol. Appl. Pharmacol. pmid:7645023
Fujii E et al. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study. 2008 Toxicol. Appl. Pharmacol. pmid:18355581
Dakhel Y and Jamali F Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. 2006 Toxicol. Appl. Pharmacol. pmid:16466760
Gray JE et al. Drug-induced enteropathy characterized by lipid in macrophages. 1974 Toxicol. Appl. Pharmacol. pmid:4136643
Gray JE et al. Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals. 1971 Toxicol. Appl. Pharmacol. pmid:4328315
Iwamoto HK and Brennan WR The effect of demeclocycline, methacycline, and erythromycin on tooth color in the rat. 1969 Toxicol. Appl. Pharmacol. pmid:4975609
Dujovne CA Liver cell culture toxicity and surfactant potency of erythromycin derivatives. 1975 Toxicol. Appl. Pharmacol. pmid:1135866
Sadrieh N and Thomas PE Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. 1994 Toxicol. Appl. Pharmacol. pmid:8048065
WORTH HM et al. INTRAGASTRIC INJECTION FOR TOXICITY STUDIES WITH NEWBORN RATS. 1963 Toxicol. Appl. Pharmacol. pmid:14082477
Gray JE et al. Foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin. 1978 Toxicol. Appl. Pharmacol. pmid:725925
Kalsotra A et al. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. 2004 Toxicol. Appl. Pharmacol. pmid:15364545
DeSalva SJ et al. Lethal effects of antibiotics in hamsters. 1969 Toxicol. Appl. Pharmacol. pmid:5787519
Gaeta GB et al. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. 1985 Toxicol. Appl. Pharmacol. pmid:2992120
Flaman AS et al. The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells. 2011 Toxicol. Appl. Pharmacol. pmid:21466820
Hayashi S et al. Characterization of multinuclear hepatocytes induced in rats by mitemcinal (GM-611), an erythromycin derivative. 2008 Toxicol Pathol pmid:18776165
Abdel-Hameid NA Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats. 2007 Toxicol In Vitro pmid:17267170
Tilmant K et al. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis. 2011 Toxicol In Vitro pmid:21515356
Peyre L et al. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. 2015 Toxicol In Vitro pmid:26239606
BARDIER A et al. [Results of infantile propiocine granulated for syrup in infections pathology in infants (Apropos of 71 cases)]. 1961 Toulouse Med pmid:13686911
BARDIER A et al. [CURRENT TREATMENT OF PLEURO-PULMONARY STAPHYLOCOCCAL INFECTIONS IN INFANTS (APROPOS OF 60 CASES)]. 1964 Toulouse Med pmid:14169371
DUBRA F [PATHOLOGY OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158172
DUBRA F [THE CURE OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158173
PALERMO FM [SECONDARY BACTERIAL RESISTANCE]. 1963 Sep-Dec Torax pmid:14159781
Giuliano MW and Miller SJ Site-Selective Reactions with Peptide-Based Catalysts. 2016 Top Curr Chem pmid:26307403
MUNOZBLAZQUEZ J [ANTIBIOTIC-CORTISONE TREATMENT OF GENITAL INFLAMMATION]. 1964 Tokoginecol Pract pmid:14108914
Hara T et al. Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy. 2006 Tokai J. Exp. Clin. Med. pmid:21302226
Partiarca PA et al. Outbreaks of pertussis in the United States: the Wisconsin experience. 1988 Tokai J. Exp. Clin. Med. pmid:3273611
Onodera T et al. Effect of fluid and antibiotic administration on experimental fecal peritonitis. 1968 Tohoku J. Exp. Med. pmid:5715596
Kanemitsu K et al. Efficacy of amikacin combinations for nocardiosis. 2003 Tohoku J. Exp. Med. pmid:14649737
Ramos CJ and Antonetti DA The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. 2017 Tissue Barriers pmid:28632993
van der Kuy A et al. [The erythromycin group]. 1974 Tijdschr Ziekenverpl pmid:4499128
van der Lely N et al. [A child with Chlamydia trachomatis pneumonia]. 1993 Tijdschr Kindergeneeskd pmid:8266317
Schurgers M et al. [A case of toxic hepatitis]. 1974 Tijdschr Gastroenterol pmid:4454054
Devriese L [Antibiotic sensitivity tests (author's transl)]. 1976 Tijdschr Diergeneeskd pmid:827819
Boswinkel M and Sloet van Oldruitenborgh-Oosterbaan MM [Diagnosis and therapy of Rhodococcus equi infection in the horse]. 2006 Tijdschr Diergeneeskd pmid:16989420
van der Toorn F and Lumeij JT [Streptococcus gallolyticus infections in racing pigeons, a literature review]. 2001 Tijdschr Diergeneeskd pmid:11227399
Bergan T [Erythromycin instead of tetracyclines to children]. 1978 Tidsskr. Nor. Laegeforen. pmid:684704
Halstensen A et al. [Treatment of infections caused by group A beta-hemolytic streptococci]. 1990 Tidsskr. Nor. Laegeforen. pmid:2120791
Ose L [Encephalitis associated with mycoplasma pneumoniae infection in children]. 1975 Tidsskr. Nor. Laegeforen. pmid:1145545
Lind O and Harthug S [Hearing loss after erythromycin therapy]. 1993 Tidsskr. Nor. Laegeforen. pmid:8211901
Aas K [Treatment of infections in allergic patients]. 1974 Tidsskr. Nor. Laegeforen. pmid:4820866
Lefsaker L et al. [Legionnaires' disease]. 1988 Tidsskr. Nor. Laegeforen. pmid:3353900
Holst-Larsen L [Antibacterial agents. 4. Erythromycin]. 1972 Tidsskr. Nor. Laegeforen. pmid:4657026
Hassel B [Acute hypothermia and adverse effects on the central nervous system during erythromycin therapy]. 1994 Tidsskr. Nor. Laegeforen. pmid:7915859